Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia
Clinical trial NCT00103727 · COMPLETED
Trial details
- NCT number
- NCT00103727
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2005-10-01
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.